LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 15.58 | 27.76 | 5 | 685 | 0.0073 | -0.3096 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 15.58 | 27.76 | 881 | 685 | 1.2851 | 1.1114 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 15.58 | 27.76 | 23 | 685 | 0.0335 | -0.0398 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 15.58 | 27.76 | 1039 | 685 | 1.5155 | 1.1881 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 17.28 | 27.76 | 10 | 838 | 0.0119 | -0.1875 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 17.28 | 27.76 | 899 | 838 | 1.0719 | 1.0284 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 17.28 | 27.76 | 28 | 838 | 0.0334 | 0.0018 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 17.28 | 27.76 | 1063 | 838 | 1.2674 | 1.0987 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 18.98 | 27.76 | 13 | 941 | 0.0138 | -0.1386 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 18.98 | 27.76 | 906 | 941 | 0.9627 | 0.9851 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 18.98 | 27.76 | 35 | 941 | 0.0372 | 0.0467 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 18.98 | 27.76 | 1072 | 941 | 1.1390 | 1.0519 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 20.68 | 27.76 | 13 | 1119 | 0.0116 | -0.1326 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 20.68 | 27.76 | 923 | 1119 | 0.8248 | 0.9291 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 20.68 | 27.76 | 37 | 1119 | 0.0331 | 0.0554 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 20.68 | 27.76 | 1049 | 1119 | 0.9374 | 0.9759 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 22.39 | 27.76 | 11 | 1305 | 0.0084 | -0.1535 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 22.39 | 27.76 | 926 | 1305 | 0.7092 | 0.8801 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 22.39 | 27.76 | 44 | 1305 | 0.0337 | 0.0864 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 22.39 | 27.76 | 1060 | 1305 | 0.8118 | 0.9263 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 24.09 | 27.76 | 13 | 1461 | 0.0089 | -0.1242 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 24.09 | 27.76 | 918 | 1461 | 0.6281 | 0.8438 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 24.09 | 27.76 | 47 | 1461 | 0.0322 | 0.0965 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 24.09 | 27.76 | 1056 | 1461 | 0.7225 | 0.8895 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 25.79 | 27.76 | 17 | 1605 | 0.0106 | -0.0804 | MN20160318_Q01 | C21 |